Fig. 2From: Immunogenicity of biologic therapies for migraine: a review of current evidenceAnti-drug antibodies and neutralizing antibodies in eptinezumab trials [28,29,30,31,32]. CM, chronic migraine; N/A, data not available; EM, episodic migraineBack to article page
